Marchex (MCHX) Q4 2025 earnings review
Platform Migration Bleeds Revenue; Future Hopes Pinned on Archenia Deal
Marchex’s core business continued to shrink in Q4, with revenue decelerating 9% YoY to $10.8 million. Management attributes this to 'revenue dilution' from migrating 1,000 customers to a new platform, effectively meaning customer churn during the transition. The bottom line deteriorated as well, with Net Loss widening to $2.3 million, heavily burdened by $1.6 million in reorganization and acquisition-related costs. While management aggressively markets 2026 as an 'inflection point' driven by AI products and the proposed acquisition of Archenia, the immediate reality is a dwindling top line and a shrinking cash position. The company is betting the house on shifting from an 'insights' provider to a 'Pay-Per-Event' outcomes model.
🐂 Bull Case
The painful transition to the new Engage platform is finally finished. With the 'revenue dilution' headwind removed, underlying growth from new AI product sales should become visible in 2026.
If successfully closed in June 2026, the Archenia acquisition brings $17M+ in profitable revenue, shifting Marchex to a highly monetizable Pay-Per-Event outcome model and boosting the pro-forma revenue run-rate to $60M.
🐻 Bear Case
Despite a multi-year 'transformation' narrative, revenue has steadily declined from $12.4M in 23Q4 to $10.8M in 25Q4. The migration cost real customers, and organic growth is yet to materialize.
The Archenia deal is a related-party transaction requiring a special committee and disinterested shareholder approval. Furthermore, Marchex’s cash balance dropped to $9.9M, raising questions about funding the $10M convertible note tied to the deal.
⚖️ Verdict: 🔴
Bearish. Management's rosy narrative of an 'inflection point' directly contradicts the reported 9% YoY revenue decline. The turnaround thesis relies entirely on aggressive future execution and closing a complex related-party acquisition, while current financials reflect a shrinking, cash-burning enterprise.
Key Themes
Migration Dilution Masks Core Weakness
Management claims the business is 'accelerating', yet Q4 revenue of $10.8M is the lowest print in over two years. The transition of ~1,000 customers to the new tech platform resulted in what management calls 'revenue dilution'—essentially customer churn or down-selling. A narrative of acceleration cannot be validated until the top line actually stabilizes and grows.
Archenia Acquisition and Pay-Per-Event Pivot
The planned Archenia acquisition is the primary catalyst for 2026. By integrating Archenia’s AI-verified outcome model, Marchex aims to pivot from selling software subscriptions (insights) to charging for verified outcomes like booked appointments. Archenia generated ~$17M in 2025 revenue, and the combined entity is projected to grow 15-20% annualized.
Related-Party Transaction Risks
The Archenia deal carries significant structural risk. Because sellers are 'related parties,' the transaction requires a fairness opinion, audited financials, and approval by a majority of disinterested stockholders. If this deal collapses, Marchex's 2026 growth narrative collapses with it.
Vertical AI Product Rollout
Marchex has expanded its proprietary technology with explicit vertical focuses (Home Services, Auto Services, Healthcare). The rollouts of AgentAI Optimizer and Marchex Engage GPT are intended to modernize the product suite and provide distinct upsell paths for existing enterprise clients.
Cash Position Deterioration
Cash and cash equivalents fell from $12.8M at the end of 2024 to $9.9M at the end of 2025. With a $10M convertible promissory note tied to the Archenia acquisition closing (payable in tranches), the balance sheet leaves very little margin for error if organic cash flow does not turn positive immediately.
Macro Pressure in Key Verticals
Management previously cited U.S. federal tariffs on imports as a headwind creating uncertainty in the Automotive and Auto Services verticals—areas where Marchex derives significant revenue. Extended macro softness in auto retail could offset any momentum gained from new AI product launches.
Other KPIs
Reversing. Gross margin in Q4 2025 fell to 61.1% (from ~63% in Q3 and ~65% in Q2). Cost of revenue remained relatively sticky at $4.2M despite the drop in total revenue, demonstrating negative operating leverage as top-line volumes declined.
Decelerating violently from +$0.6M in Q3. However, this includes $1.6M in one-time reorganization and acquisition-related costs. Excluding these, Adjusted EBITDA would have been a positive $0.4M, indicating that underlying cost control is somewhat intact despite the revenue hit.
Guidance
Stable. Management guides Q1 2026 revenue to be 'in the range of fourth quarter 2025 levels.' This confirms that the step-down in revenue is the new baseline, and the previously promised sequential growth will not begin until at least Q2.
Reversing. Moving from a reported $1.2M loss in 25Q4 back into positive territory, assuming the absence of further heavy reorganization charges.
Accelerating. Management expects sequential quarterly revenue increases throughout 2026, building to a 10% run-rate growth from 2025 year-end levels. This assumes the new AI solutions offset any lingering platform migration churn.
Accelerating. An aggressive target to reach double-digit margins by year-end, driven by the combination of higher expected revenue and an optimized, lower operating expense structure post-migration.
Key Questions
True Cost of Migration
You cited 'revenue dilution' from the platform migration. What was the exact logo churn rate among the 1,000 migrated customers, and how much of the Q4 revenue drop is permanently lost versus delayed?
Funding the Acquisition
With the cash balance down to $9.9M and the Archenia deal involving a $10M convertible note, how do you plan to fund the tranches of this note alongside normal working capital needs without highly dilutive external financing?
Related Party Deal Safeguards
Given that Archenia is a related-party transaction, what specific contingencies are in place if disinterested shareholders reject the deal, and what is the standalone growth plan if the acquisition fails to close in June 2026?